Pharm - Gout Flashcards
acute gout attack goals
managing inflammation
chronic hypERuricemia
lowering uric acid
colchicine
MOA/AE
MOA: microtubule inhibitor, downregulates TNF/blocks COX2, inhibits wbc migration
AE: GI (N/V/D, abd pain)
neuromyopathy mimicking polyangitis (rare)
If a patient cannot tolerate NSAIDS because of such issues as hypersensitivity, fluid overload, renal insufficiency, or peptic ulcer disease, then _______ are acceptable alternatives most commonly used.
colchicine and glucocorticoids
____ is used for tx of acute gout attacks (as well as for prophylaxis against new attacks)
Colchicine
____ must be given in first 24 hr of gout attack
Colchicine
____ are two drugs which reduce production of uric acid and are indicated for chronic therapy in patients with problems of over-production of uric acid.
Allopurinol and febuxostat
____ are uricosuric agents indicated for patients who are under-excreters of uric acid.
Probenecid and sulfinpyrazone
refractory gout tx
IL-1 inhibitors (anakinra, canakinumab)
indic for pharm tx of chronic hypERuricemia
- 2+ attacks in past year
- uric acid kidney stones
- tophi
- renal insufficiency
- CHF necessitating long-term, or a very serum uric acid
uricosuric agents
probenecid
lesinurad
XO inhibitors
allopurinol
febuxostat
urate oxidase enzyme
pegloticase
genetic predisposition to severe allipurinol toxicity
HLA B5801